The New South Wales government has unveiled a significant strategy to bolster its high-tech sector, launching a new $20 million fund to support startups. This initiative, the Emerging Technologies Commercialisation Fund, was announced alongside the successful recipients of two other major grant programs. These combined efforts underscore the government's commitment to transforming world-class research into market-ready products and solidifying NSW's position as a leading innovation hub.
A New Funding Model for Startups
The centerpiece of the announcement is the $20 million Emerging Technologies Commercialisation Fund (ETCF), a multi-year initiative designed to support innovative young companies. The program offers repayable grants, functioning as loans valued between $500,000 and $2 million. Repayment is triggered only after a startup achieves an annual EBITDA of over $500,000, providing a flexible pathway to growth.
This fund specifically targets the well-documented "innovation gap," where promising technologies struggle to secure the capital needed for maturation. By providing this crucial support, the government aims to de-risk development and accelerate commercialization outcomes for early-stage companies. The initiative is strategically aligned with state priorities, including net zero emissions, housing, and local manufacturing capabilities.
Aspiring companies must demonstrate patience, as the application process for the first $7 million round is extensive. The competitive, three-step procedure involves a preliminary application, a full application by invitation, and a final interview stage. The successful recipients for this initial round are not expected to be announced until October 2026.
Celebrating Breakthroughs in Biosciences
Alongside the new fund, the government celebrated the recipients of the $4.75 million Biosciences Fund, which supports biotechnology and life sciences startups. Four companies were awarded grants for their pioneering work in diverse sectors ranging from advanced nutrition to renewable energy. These recipients exemplify the high-caliber innovation emerging from the state's research and development ecosystem.
Among the recipients, All G is working to replicate the complex composition of human breast milk to enhance infant formula. Meanwhile, HydGene Renewables has developed a biocatalyst technology that converts waste biomass into green hydrogen for producing key industrial molecules. Both companies are tackling significant global challenges with their cutting-edge scientific approaches.
The other awardees are also addressing critical issues, with Number 8 Bio tackling livestock methane emissions through a novel inhibitor molecule. Swan Genomics is developing a simpler and more affordable DNA sequencing technology to improve accessibility in regional hospitals and diagnostic labs. These innovations highlight the fund's focus on creating tangible environmental and healthcare benefits.
Advancing RNA Therapeutics
Furthering its commitment to medical science, the government also announced the two recipients of the $6 million RNA Pipeline Grants program. Platypus Bio and Vaxosome were selected for their work in developing innovative RNA-based therapies and vaccines. This program is instrumental in building a robust pipeline of RNA products that can leverage the state's new manufacturing facilities.
Platypus Bio is developing a highly targeted RNA therapeutic designed to activate exclusively within cancer cells, destroying them while leaving healthy tissue unharmed. In a similar vein, Vaxosome is creating a next-generation mRNA vaccine to address the limitations of current treatments for tuberculosis. These projects represent the forefront of modern medical research and therapeutic development.
The NSW government's latest announcements represent a comprehensive and strategic investment in the state's innovation landscape. By launching the repayable ETCF and rewarding groundbreaking research in biosciences and RNA technology, the state is fostering a supportive ecosystem for high-tech commercialization. These initiatives are poised to create high-value jobs and cement NSW's reputation as a premier destination for starting and scaling an innovative business.